Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

Quizartinib FLT3 inhibitor status – Hagop Kantarjian

Editor By No Comments1 Min Read

Hagop Kantarjian, MD of MD Anderson Cancer Center discusses Quizartinib FLT3 inhibitor status at the Scripps 36th Annual Conference: Clinical Hematology and Oncology in San Diego.

Share.

Related Posts